We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$19.2B
AUM Growth
+$2.52B
Cap. Flow
+$1.25B
Cap. Flow %
6.54%
Top 10 Hldgs %
17.34%
Holding
2,313
New
197
Increased
1,021
Reduced
855
Closed
212

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 15.67%
3 Healthcare 9.34%
4 Consumer Discretionary 9.15%
5 Real Estate 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRT icon
1751
Independence Realty Trust
IRT
$4.07B
$434K ﹤0.01%
+16,784
New +$397K
CORT icon
1752
Corcept Therapeutics
CORT
$12B
$433K ﹤0.01%
21,860
-42,120
-66% -$854K
URBN icon
1753
Urban Outfitters
URBN
$6.59B
$433K ﹤0.01%
14,747
-1,133
-7% -$35.9K
RILY icon
1754
BRC Group Holdings
RILY
$289M
$432K ﹤0.01%
+4,865
New +$356K
VSXY
1755
Victoria's Secret
VSXY
$7.83B
$431K ﹤0.01%
7,755
+290
+4% +$15.1K
WPP icon
1756
WPP
WPP
$5.94B
$431K ﹤0.01%
5,705
+1,450
+34% +$103K
PINC
1757
DELISTED
Premier
PINC
$429K ﹤0.01%
10,432
-2,140
-17% -$84.4K
LHCG
1758
DELISTED
LHC Group LLC
LHCG
$429K ﹤0.01%
3,128
-1,295
-29% -$177K
TFIN icon
1759
Triumph Financial Inc
TFIN
$1.82B
$428K ﹤0.01%
3,594
+1,231
+52% +$147K
ZIM icon
1760
ZIM Integrated Shipping Services
ZIM
$3.24B
$428K ﹤0.01%
+7,274
New +$372K
OI icon
1761
O-I Glass
OI
$1.08B
$427K ﹤0.01%
35,490
+17,510
+97% +$222K
XENE icon
1762
Xenon Pharmaceuticals
XENE
$6.12B
$427K ﹤0.01%
13,684
+3,609
+36% +$108K
ARCB icon
1763
ArcBest
ARCB
$3.08B
$425K ﹤0.01%
3,547
-1,975
-36% -$201K
FOLD
1764
DELISTED
Amicus Therapeutics
FOLD
$425K ﹤0.01%
36,755
-130,987
-78% -$1.46M
MFD
1765
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
$425K ﹤0.01%
44,060
-29,017
-40% -$280K
BWCAW
1766
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
$425K ﹤0.01%
+499,994
New +$466K
NBW
1767
DELISTED
Neuberger Berman California Municipal Fund Inc.
NBW
$423K ﹤0.01%
30,194
+14,860
+97% +$207K
UNVR
1768
DELISTED
Univar Solutions Inc.
UNVR
$411K ﹤0.01%
14,507
-33,264
-70% -$898K
ZTO icon
1769
ZTO Express
ZTO
$17.9B
$410K ﹤0.01%
14,532
-262
-2% -$7.82K
MFC icon
1770
Manulife Financial
MFC
$73.5B
$405K ﹤0.01%
21,258
-28,263
-57% -$547K
CLB icon
1771
Core Laboratories
CLB
$521M
$404K ﹤0.01%
18,107
-30,097
-62% -$785K
WERN icon
1772
Werner Enterprises
WERN
$2.25B
$403K ﹤0.01%
8,451
+2,460
+41% +$113K
ITCI
1773
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$402K ﹤0.01%
+7,691
New +$323K
GPRE icon
1774
Green Plains
GPRE
$1.03B
$400K ﹤0.01%
11,501
-16,973
-60% -$631K
CNI icon
1775
Canadian National Railway
CNI
$76.6B
$399K ﹤0.01%
3,244
-1,108
-25% -$140K

Similar funds

Guggenheim Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Guggenheim Capital held 2,313 positions worth $19.2B, up 15% from $16.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital deployed $1.25B of net new capital in Q4 2021, opening 197 new positions and adding to 1,021 existing holdings. Its largest new stake was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Tesla, an estimated $28.7M trimmed.

  • Guggenheim Capital's largest Q4 2021 buy was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.
  • Guggenheim Capital added most to FIGS in Q4 2021, an estimated $173M increase.
  • Guggenheim Capital's biggest Q4 2021 reduction was Tesla, cutting an estimated $28.7M.
  • Guggenheim Capital fully exited AfterNext HealthTech Acquisition Corp Units in Q4 2021, selling an estimated $37.1M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $19.2B portfolio in Q4 2021.
  • Guggenheim Capital opened 197 new positions and closed 212 in Q4 2021.
  • Guggenheim Capital's portfolio value rose 15% quarter-over-quarter to $19.2B.

Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.